Hefei Lifeon Pharmaceutical's application for the listing of neneftorone raw materials has been accepted.

11:48 10/02/2026

Cubic Pharmaceutical (003020.SZ) announced that the company has received the "Acceptance Notice" for the application for the listing of spironolactone raw materials issued by the National Medical Products Administration. Spironolactone is a novel, non-steroidal, selective mineralocorticoid receptor antagonist (MRA), and its formulation is used in adult patients with chronic kidney disease associated with type 2 diabetes, reducing the risk of continuous decline in eGFR and end-stage renal disease.

Hefei Lifeon Pharmaceutical (003020.SZ) announced that the company has received the "Acceptance Notice" for the application to list nefeidalone as an active pharmaceutical ingredient from the National Medical Products Administration. Nefeidalone is a novel, non-steroidal, selective mineralocorticoid receptor antagonist (MRA). Its formulation is used in adult patients with chronic kidney disease associated with type 2 diabetes, and can reduce the risk of continuous decline in eGFR and end-stage renal disease.

NT PHARMA (01011) will be suspended from trading starting February 10, awaiting the publication of supplementary information related to the issuance of convertible bonds.

J.P. Morgan first gives MiniMax (00100) a "overweight" rating: Global AI pioneer, leading the next wave of value trends.

StanChart (02888) appoints Peter Burrill as Acting Group Chief Financial Officer

NT PHARMA (01011) will be suspended from trading starting February 10, awaiting the publication of supplementary information related to the issuance of convertible bonds.

J.P. Morgan first gives MiniMax (00100) a "overweight" rating: Global AI pioneer, leading the next wave of value trends.

StanChart (02888) appoints Peter Burrill as Acting Group Chief Financial Officer